Prothena Corp Public (PRTA) Non Operating Income (2013 - 2026)

Prothena Corp Public (PRTA) recorded quarterly Non Operating Income of $2.7 million in Q1 2026, up 12313.64% quarter-over-quarter from -$22000.0 in Q4 2025, and up 2019.29% on a YoY basis from $126788.0 in Q1 2025.

Prothena Corp Public (PRTA) Non Operating Income (2013 - 2026) Analysis & Trends

Prothena Corp Public's Non Operating Income history runs 14 years deep, the most recent figure standing at $2.7 million for Q1 2026.

  • In Q1 2026, Non Operating Income rose 2019.29% year-over-year to $2.7 million; the TTM figure through Mar 2026 stood at $2.5 million (down 78.97% YoY), while the FY2025 annual figure was -$328000.0, down 101.28% from the prior year.
  • Non Operating Income was $2.7 million for Q1 2026 at Prothena Corp Public, up from -$22000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $7.1 million in Q1 2024 to a low of -$327000.0 in Q4 2022.
  • Historically, Non Operating Income has averaged $1.3 million across 5 years, with a median of -$23000.0 in 2025.
  • The sharpest annual moves came in 2022 and 2024: Non Operating Income plunged 1357.69% in 2022, then surged 44613.33% in 2024.
  • A 5-year view of Non Operating Income shows it stood at -$327000.0 in 2022, then soared by 37.31% to -$205000.0 in 2023, then jumped by 2732.2% to $5.4 million in 2024, then plunged by 100.41% to -$22000.0 in 2025, then surged by 12313.64% to $2.7 million in 2026.
  • The last three Non Operating Income figures came in at $2.7 million (Q1 2026), -$22000.0 (Q4 2025), and -$23000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 5.75 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 444,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - 9.35 Mn
10 Prothena Corp Public 479.08 Mn 149.61 Mn - 2.69 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.69 Mn
Dec 31, 2025 -22,000.00
Sep 30, 2025 -23,000.00
Jun 30, 2025 -143,000.00
Mar 31, 2025 -140,000.00
Dec 31, 2024 5.40 Mn
Sep 30, 2024 6.68 Mn
Jun 30, 2024 -51,000.00
Mar 31, 2024 7.09 Mn
Dec 31, 2023 -205,000.00
Sep 30, 2023 -15,000.00
Jun 30, 2023 -97,000.00
Mar 31, 2023 -141,000.00
Dec 31, 2022 -327,000.00
Sep 30, 2022 2,000.00
Jun 30, 2022 690,000.00
Mar 31, 2022 -70,000.00
Dec 31, 2021 26,000.00
Sep 30, 2021 -42,000.00
Jun 30, 2021 -53,000.00